HGEN vs. NOVN, NOVNQ, VRAYQ, AHPI, STAB, UTRS, HTGMQ, GNCAQ, GNCA, and SCPS
Should you be buying Humanigen stock or one of its competitors? The main competitors of Humanigen include Novan (NOVN), NVN Liquidation (NOVNQ), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Statera Biopharma (STAB), Minerva Surgical (UTRS), HTG Molecular Diagnostics (HTGMQ), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), and Scopus BioPharma (SCPS). These companies are all part of the "medical" sector.
Humanigen (NASDAQ:HGEN) and Novan (NASDAQ:NOVN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.
Novan received 216 more outperform votes than Humanigen when rated by MarketBeat users. However, 57.50% of users gave Humanigen an outperform vote while only 56.24% of users gave Novan an outperform vote.
Novan has higher revenue and earnings than Humanigen.
Humanigen has a net margin of 0.00% compared to Novan's net margin of -128.61%. Humanigen's return on equity of 0.00% beat Novan's return on equity.
In the previous week, Humanigen's average media sentiment score of 0.00 equaled Novan'saverage media sentiment score.
4.6% of Humanigen shares are owned by institutional investors. Comparatively, 14.5% of Novan shares are owned by institutional investors. 21.7% of Humanigen shares are owned by insiders. Comparatively, 1.3% of Novan shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Humanigen has a beta of -1.04, indicating that its share price is 204% less volatile than the S&P 500. Comparatively, Novan has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500.
Summary
Humanigen and Novan tied by winning 5 of the 10 factors compared between the two stocks.
Get Humanigen News Delivered to You Automatically
Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Humanigen Competitors List
Related Companies and Tools
